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Abstract
Objective and methods: Based on nationwide death certificates, a cluster of amyotrophic lateral sclerosis (ALS) has been
reported in the area of Briga (Novara province, northern Italy), known for its severe environmental contamination. We
further investigated this finding, by following up with the collection of recent incidence ALS data in 2002–2012 of Novara
province, also to assess the possible long-term effects of environmental pollution in that area. Results: In the whole Novara
province we identified 106 ALS cases, of which 35 were from the Briga area. Incidence rates of Novara province were 3.98,
5.14 and 2.97 for the total population, males and females, respectively, compared with the Briga area where they were 4.65,
4.27 and 4.98, respectively. The ratio of observed-to-expected ALS cases in the Briga area, using incidence of the rest of
Novara province as a reference, was 1.17 (95% CI 0.81–1.62), with a value of 0.83 (95% CI 0.47–1.37) in males and 1.68
(95% CI 1.03–2.60) in females. Conclusions: Overall, our study did not confirm previous findings of an excess ALS
incidence in an area characterised by severe environmental heavy metal pollution, and it suggests the need to interpret with
caution clusters identified through mortality data.
KEYWORDS: Amyotrophic lateral sclerosis, incidence study, environmental pollution, heavy metals
Introduction
Amyotrophic lateral sclerosis (ALS) is an adult-
onset, fatal disorder, characterised by degeneration
of both upper and lower motor neurons. Clinical
presentation of ALS includes muscle atrophy and
weakness. Subsequently, spreading paralysis of the
voluntary muscles often develops, and eventually of
the respiratory muscles. Approximately half of
patients with ALS die within 30 months from
symptoms onset, usually from respiratory insuffi-
ciency, whereas about 10% of patients may survive
for more than a decade (1–5). About 5–10% of ALS
patients have a familial form (6). If no family history
is identified, the disease is assumed to be sporadic.
Worldwide, ALS incidence ranges from 2 to
4/100,000 people per year with the exception of
some high-risk areas around the Pacific Rim such as
Guam or parts of Western New Guinea (7). In
Europe, the median annual incidence rate is around
2 cases/100,000/year, while the median prevalence is
over 5 cases/100,000 population (8).
The aetiology of ALS is still unknown. Genetic
factors play a major role in the familial form (9),
while for the aetiology of the sporadic form several
environmental and life-style factors might be
involved, such as heavy metals (particularly lead
and mercury) and the metalloid selenium, solvents,
pesticides, electric shocks and electromagnetic
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fields, smoking, severe head trauma and intense
sport activity (10–12).
Generally, ALS is rare before the age of 40 years;
thereafter it increases with age with a peak incidence
in those aged 70–79 years; male:female ratio ranges
from 1.2 to 1.5 (13). Mean age at onset ranges from
58 to 63 years for the sporadic form and 40 to
60 years for the familial form (14–20).
During recent decades, an increasing mortality
or incidence of ALS has been reported in some
countries, although this has not been observed
elsewhere (21–33). In addition, there is evidence
for an uneven distribution of the disease in several
countries, suggesting a potential role of environ-
mental factors. In Italy, a study describing the
distribution of ALS mortality in the period 1980–
2001 has detected 16 single clusters scattered
throughout the country, i.e. municipalities with
higher mortality rates for motor neuron disease, a
disease almost entirely represented by ALS. One of
these clusters, based on 54 ALS deaths, was
detected in the province of Novara (Piedmont,
northern Italy), and Briga Novarese municipality
was the centroid of this area of 10 km radius
(Figure 1) (34).
The Briga area is known for its heavy level of
metal contamination due to metal production plants
in the area, particularly for domestic tap production.
Heavy metals originating from discharge water of
metal production activities had great impact on soil,
surface water and groundwater quality in the Briga
area (35).
We here report a further investigation of these
findings, through the collection of incidence ALS
data in the period 2002–2012 from the Briga area,
and also assess the possible involvement of environ-
mental pollution in ALS aetiology in that area.
Methods
Study area
The study area is the province of Novara, located in
Piedmont Region (northern Italy) with an extension
area of 1300 km2. During the study period, the
population increased and varied from 340,000
persons in 2002 to up to 360,000 persons in 2012
with a population density of approximately 270
inhabitants/km2. In the Novara province there are
five main municipalities: Novara, the largest, with
100,000 inhabitants (inh), Trecate (20,000 inh),
Galliate (16,000 inh) in the south, Borgomanero
(22,000 inh) and Arona (14,000 inh) in the north,
and other small towns with less than 3,000
Figure 1. (A) Province of Novara and municipalities of the Briga area (gray area): Agrate Conturbia, Ameno, Armeno, Arona, Boca,
Bogogno, Bolzano Novarese, Borgomanero, Briga Novarese, Cavallirio, Colazza, Comignago, Cressa, Cureggio, Dormelletto, Fontaneto
d’Agogna, Gargallo, Gattico, Gozzano, Grignasco, Invorio, Maggiora, Meina, Miasino, Nebbiuno, Oleggio Castello, Orta San Giulio,
Paruzzaro, Pella, Pettenasco, Pisano, Pogno, Prato Sesia, Romagnano Sesia, San Maurizio d’Opaglio, Veruno, Soriso. Area of Briga and
Borgomanero (black circle) interested by the study on soil, groundwater quality of ARPA Piemonte 2010 (35) B) District of taps of the
province of Novara (gray area), adapted from Rogatti et al. 2013 (63).
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inhabitants. Generally, the land is flat in the south,
mainly devoted to rice and maize production; other
prominent activities are industrial manufacture and
service industries. Furthermore, in Trecate, sur-
rounding the suburbs of Milan province, there is
significant oil refining. The north is hilly and
characterised by forests and vineyards. Finally, in
the southern area near Lakes Orta and Maggiore,
there is intensive cultivation of flowers in green-
houses and a great number of metal production
plants, particularly specialising in the manufacture
of water valves and household taps (Figure 1). In
this latter area, henceforth named as the ‘Briga
area’, the number of tap production units increased
from 69 in 1961 to 300 in 1991, with, respectively,
110 and 3083 workers and exports of more than 600
billion lire in 1994. Furthermore from 1991 to 1998
a 22% of workers increase was registered, although
the production units did not significantly increase.
Overall, around 22% of the labour force was
involved in tap production units, excluding domestic
production involvement of family members (36).
According to the Novara Chamber of Commerce,
Industry, Craft and Agriculture , in the three main
municipalities of Briga area, Gozzano, Briga
Novarese and Borgomanero, there were still, res-
pectively, 56 (4.66/km2), 20 (4.2/km2) and 29
(0.9/km2) production units in the metalworking
sector in 2010 (35). Furthermore, until the 1950s,
in this area tap production was carried out typically
within artisan enterprises thanks to an ancient
tradition linked to the processing of ferrous materials
and assigning to females the task of the preparation
of casting molds at their own home (37).
Environmental pollution
There is clear evidence of the occurrence of severe
environmental pollution in the Briga area. The
Regional Agency for the Protection of the
Environment of Piedmont (ARPA) showed severe
environmental pollution from heavy metals, espe-
cially for As, Sn, Pb and Zn, in soils of the Briga area
compared to Novara province and, more generally,
the overall Piedmont region, due to a common
antropic origin (35). In the same area, there are 15
contaminated sites ascribed to the Regional Register
resulting from uncontrolled discharges (e.g. metals
and heavy metals) from the production units until
the mid-1990s (38). Specific studies on the water of
upper aquifers of the contaminated sites showed
concentrations of Al, Mn, Ni, Pb, total Cr beyond
the limits of the D.Lgs. 152/2006 (39), the Italian
standards relating to the environment. Deeper
groundwater intended for human consumption was
under the mandatory limits of D.Lgs.31/2001, the
Italian standards on drinking water quality, and
D.Lgs.152/2006 always distributed to the popula-
tion (39,40). Surface waters showed poor condition,
always due to discharges from earlier metal
industries.
Data collection and analysis
In order to collect data of all incident ALS cases in the
province of Novara in the period 2002–2012, different
databases have been examined. Data from the
registries of hospital discharge records (using the
335.20 code of International Classification of Diseases
9 Clinical Modification - ICD-9-CM) have been
collected from the Regional Expert Centre for ALS
(CRESLA) at the Hospital of Novara and the
Neurology Department of Veruno. Hospital discharge
records are mandatory nationwide, and are a reliable
source of data. Moreover, they are continuous over
the study period and allowed to collect cases that had
been treated in the two hospitals considered as
reference centres for ALS health care services in the
study area. We also consulted the Piemonte and Valle
d’Aosta registry for ALS (PARALS) at the University
of Turin (41) and data from death certificates of the
archives of Novara, Vercelli and Omegna Local Health
Districts in order to avoid loss of cases identification
outside their province or region of residence.
Only ‘clinically definite’, ‘clinically probable’ and
‘clinically probable-laboratory-supported’ ALS cases
according to the El Escorial-revised classification
(rEEC) have been included, along with the date of
diagnosis (42). Each diagnosed case has been
validated by evaluation of medical history and any
possible duplication has been correctly identified.
Moreover, a clinical follow-up (2–4 months) of each
patient has been performed by PARALS and
Neurology units, thus rEEC diagnosis of ‘clinically
possible’ ASL cases has been verified and, if neces-
sary, switched in the categories considered above, or
discharged as other neurological diseases (41).
Indirect standardisation was carried out con-
sidering the resident population from 2002 to 2012
and dividing it into five age classes (35–44, 45–54,
55–64, 65–74 and475 years). We used age-specific
rates in the Novara province population after
excluding residents in the Briga area, to compute
the expected number of cases in the Briga area, and
we calculated the incidence ratio between the total
number of observed cases versus the number of
expected ones. Finally, for the total population,
males and females, the standardised incidence ratio
(SIR) was calculated.
This research was approved by the Ethics
Committee of the University of Milan, and of
the Ospedale Maggiore della Carità of Novara and
the ICS Maugeri of Veruno. All data are presented
in an anonymised form and only pooled data are
reported. Finally, data analyses were performed
using software Excel (Office package 2010) and
Stata (Version 14.2, Stata Corp. College Station,
TX 2015).
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Results
In the period from 2002 to 2012 in the province of
Novara we identified 106 ALS cases from hospital
discharge registers, cross-checked with data from
death certificates and PARALS (Figure 2). In the
whole province, we observed from six new cases of
ALS in 2003 to 15 new cases in 2012, with a median
value of nine new cases per year and crude incidence
rate of 2.5 cases/100,000 persons. Table 1 shows
median age and sex distribution of selected cases
according to study area. Thirty-five subjects out of
106 cases were residents in the investigated area of
Briga Novarese, with 15 males and 20 females (43%
vs. 57%, respectively), leading to a male:female ratio
of 0.75, while 71 lived in the remainder of the
province of Novara, with 43 males and 28 females
(61% vs. 39%, respectively), with a male:female
ratio of 1.54. According to age groups, we identified
an increasing number of cases with increasing age.
This trend is still evident for both sexes in the two
areas, except for the age class over 75 years in the
Briga area. The lowest number of cases was found in
the age class 35–44 years, both in the Briga area and
in the rest of the province (Table 2).
For the period 2002–2012, the number of
observed cases and incidence rates of the rest
of the Novara province and Briga area, number of
expected cases in Briga area, incidence ratio and SIR
with 95% CI are reported for the total population,
males and females and age groups in Table 2.
Incidence rates of Novara province were 3.98, 5.14
and 2.97 for the total population, males and
females, respectively. Overall incidence rates in the
Briga area were 4.65, 4.27 and 4.98 for the total
population, males and females, respectively.
Comparing the number of expected to observed
cases in the total Briga population, we found an
excess of five cases (30 expected vs. 35 observed
cases), mainly due to an excess in females (12 vs. 20
cases) rather than males (18 vs. 15 cases). SIR
analysis showed a value of 1.17 (95% CI 0.81–1.62)
for the total population, with SIR respectively lower
in males (0.83, 95% CI 0.47–1.37) and higher in
females (1.68, 95% CI 1.03–2.60). When we
stratified for age groups, we found incidence ratios
of 9.92 (95% CI 2.70–25.40) for males in the 45–54
years age class and of 3.64 (95% CI 1.82–6.52) for
females in the 65–74 years age class, which corres-
ponds to two or three times, respectively, the
observed than the expected cases in the Briga area.
Discussion
In this study, we investigated recent ALS incidence
in an Italian province where severe environmental
pollution from industrial chemicals has occurred.
Previous studies in the same or neighbouring Italian
regions reported an incidence of 3.46 (95% CI
2.83–4.20) in Novara province and 3.41 (95% CI
Figure 2. Flow diagram of identification of ALS cases from difference database sources.
Table 1. Median age and sex distribution of ALS cases in the study period (from 2002 to 2012) for total Novara province, Briga area and
the rest of the Novara province.
Total Males Females
n Median Age Range M/F ratio n Median Age Range n Median Age Range
Briga area 35 67 44–87 0.75 15 63 44–87 20 68 50–87
Rest of Novara Province 71 72 35–88 1.54 43 71 35–88 28 73 45–82
Total 106 70 35–88 1.21 58 69 35–88 48 70 45–87
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3.22–3.60) in Piedmont Region in the period 1995–
2004 (43), 3.22 (95% CI 2.66–3.90) in Liguria in
2009–2010 and male:female ratios were, respect-
ively, 1.28 and 1.34 (44). In Emilia Romagna
Region in the period 2009–2011, the incidence
rate was 2.54 (95% CI 2.51–2.56), ranging from
2.01 in Parma and 3.34 in Modena, and male-to-
female ratio was 1.17 (33,45). In Europe, the
median incidence rate based on 21 studies encom-
passing the period 1990–2009 was 2.08 (interquar-
tile range 1.47–2.43) (8). In the period 2002–2012
indirect standardised incidence was 4.65 in the
Briga area and male:female ratio was 0.75, while in
the rest of Novara province incidences were 3.98
and 1.54, respectively. Generally, males present
higher incidence than females, ranging from 2.97
vs. 2.32 in Piedmont (41), and 3.71 vs. 2.77 in
Liguria (44). Overall, the epidemiology of the
disease in the entire Novara province confirmed
the widely observed age-related increase, and thus
we could observe a peak in the 65–74-years age class
both in the Briga area and the rest of the province
(41,44), despite our estimates being based on a
relatively small number of cases.
Our results did not appear to confirm the
presence of the previously described cluster of
ALS in the study area and specifically in the area
of Briga, which was long-term characterised by a
severe degree of environmental pollution (34).
Therefore, they seemed to not confirm the hypoth-
esis that heavy metal pollution plays an important
role in the aetiology of the disease, as suggested by
some studies (46–49) but not by other observations
(50).
The Briga area we investigated was characterised
by severe environmental pollution from heavy
metals such as As, Zn, Sn, Pb and Cu compared
to the Novara province and Piedmont Region, due
to widespread antropic contamination. In addition,
the high As and Zn concentrations suggest elevated
presence of these two elements in the bedrock. Very
high Pb levels have also been detected in ground-
waters in the investigated area (35), and these heavy
metals have been suggested by some studies to
increase ALS risk (51). In addition, studies on
surface waters, groundwaters and soil in that area
have shown high concentrations of other potentially
neurotoxic elements such as Al, Mn, Cu, Zn, Ni,
and total Cr (35,39).
The slightly higher incidence in females in the
Briga area conflicts with previous findings. A pos-
sible explanation could be found in the high expos-
ure of females to metals during processing of tap
manufacture in their homes. The increasing urban-
isation and economic boom since the 1950s allowed
the consolidation and expansion of some companies
and the creation of new businesses by a process of
budding, especially small family businesses.
Traditionally, females were involved in some par-
ticular aspects of tap manufacture that could be
performed in their homes, leading to frequent
dermal contact and inhalation of metal dust
(36,37). A meta-analysis evaluating the association
between ALS and occupational exposure to
Table 2. Number of observed cases and incidence rates of the rest of Novara province and Briga area, number of expected cases in Briga
area, incidence ratio and Standardised Incidence Ratio (SIR) with 95% confidence interval (CI) for the total population, males and females
and age groups in the period 2002–2012.














(95% CI) SIR (95% CI)
Total
35–44 5 1.07 1 0.52 (0.00–3.01) 2.1 0.49 (0.01–2.72)
45–54 7 1.74 6 3.67 (1.32–8.05) 2.9 2.11 (0.77–4.59)
55–64 16 4.69 5 3.41 (1.08–8.03) 6.9 0.73 (0.24–1.70)
65–74 19 6.31 14 10.73 (5.85–18.06) 8.2 1.70 (0.93–2.86)
475 24 8.78 9 7.39 (3.35–14.10) 10.7 0.84 (0.39–1.60)
Overall 71 3.98 35 4.65 (3.24–6.47) 30.0 1.17 (0.81–1.62)
Males
35–44 5 2.11 1 1.02 (0.00–5.84) 2.1 0.49 (0.01–2.69)
45–54 1 0.49 4 4.90 (1.27–12.67) 0.4 9.92 (2.70–25.40)
55–64 11 6.63 2 2.81 (0.27–10.34) 4.7 0.42 (0.05–1.53)
65–74 12 8.84 3 5.08 (0.96–15.04) 5.2 0.58 (0.12–1.68)
475 14 14.62 5 12.10 (3.82–28.47) 6.0 0.83 (0.27–1.93)
Overall 43 5.14 15 4.27 (2.38–7.06) 18.1 0.83 (0.47–1.37)
Females
35–44 0 0 0 – – –
45–54 6 3.01 2 2.45 (0.23–9 .00) 2.5 0.81 (0.10–2.94)
55–64 5 2.85 3 3.98 (0.75–11.79) 2.2 1.40 (0.29–4.08)
65–74 7 4.23 11 15.41 (7.65–27.67) 3.0 3.64 (1.82–6.52)
475 10 5.63 4 4.97 (1.29–12.86) 4.5 0.88 (0.24–2.26)
Overall 28 2.97 20 4.98 (3.04–7.71) 11.9 1.68 (1.03–2.60)
aCases per 100,000 persons.
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chemical agents indicated a stronger association in
females than in males for such metals (especially
chromium and lead) (52).
This study has some limitations. First, incidence
estimates were generally imprecise due to small
number of cases, as indicated by the wide confi-
dence intervals of the estimates. However, the
sample size was adequate to allow the detection of
a strongly increased risk, should it have been as high
as previously documented: a former mortality study
was based on 54 deaths in the period 1980–2001,
while our incidence data detected 106 newly-
diagnosed cases in the period 2002–2012.
Furthermore, the study design did not include
collection of occupational and environmental expos-
ure to chemicals for each subject, in order to assess
specific ALS risk factors. Therefore, we are planning
to conduct an ad hoc case-control study evaluating
specific and personal exposure to environmental
pollutants, including occupational exposure espe-
cially in subjects directly involved in the metal
industry.
A plausible interpretation of the lack of consist-
ency between our results and the previously
described cluster of ALS in the polluted area can
be due to a more reliable and comprehensive
methodology in case retrieval and ascertainment
compared with the previous investigation based on
ALS mortality only (34). Furthermore, the mortal-
ity data could be influenced by a higher notification
rate by the Department of Neurologic
Rehabilitation of Veruno hospital which was one of
the first reference centres for ALS diagnosis and
treatment in the study area.
Strengths of our study included the use of
incidence rather than mortality data, the use of
reliable databases including hospital discharges rec-
ords and Piemonte and Valle d’Aosta registry for
ALS (PARALS) and the specific validation of
included cases using medical history data. Finally,
the indirect standardisation methods allowed a better
ALS incidence estimation, considering the rarity of
the disease, while the previous study was based on
direct standardisation or only on mortality data.
In conclusion, our study does not confirm
previous findings carried out in the same area, also
suggesting that studies of ALS clusters based on
mortality data are potentially biased for methodo-
logical weaknesses and should be considered with
strong caution when addressing the hypothesis of
the environmental aetiology of ALS. However, also
taking into account some evidence from the epi-
demiological literature (2,11,12,49), the relation
between environmental pollution and ALS risk is
clearly worth further investigation.
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